Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
Autor: | Diana Kouiavskaia, Fetweh H. Al-Saleem, Chandana Devi Kattala, Konstantin Chumakov, Rama Devudu Puligedda, Jiang-Yang Zhao, Vladimir Vigdorovich, Scott K. Dessain, D. Noah Sather |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
lcsh:Immunologic diseases. Allergy medicine.drug_class Immunology circulating vaccine derived polioviruses On-Cell mAb Screening Monoclonal antibody medicine.disease_cause Neutralization Article hybridoma methods law.invention 03 medical and health sciences 0302 clinical medicine law Drug Discovery medicine Immunology and Allergy OCMS™ 030212 general & internal medicine biology poliovirus Chemistry Poliovirus Wild type cVDPV human antibodies Molecular biology Protein L 030104 developmental biology Immunoglobulin class switching biology.protein Recombinant DNA monoclonal antibodies Antibody lcsh:RC581-607 IgA |
Zdroj: | Antibodies Volume 9 Issue 1 Antibodies, Vol 9, Iss 1, p 5 (2020) |
ISSN: | 2073-4468 |
Popis: | Poliovirus (PV)-specific intestinal IgAs are important for cessation of PV shedding in the gastrointestinal tract following an acute infection with wild type or vaccine-derived PV strains. We sought to produce IgA monoclonal antibodies (mAbs) with PV neutralizing activity. We first performed de novo IgA discovery from primary human B cells using a hybridoma method that allows assessment of mAb binding and expression on the hybridoma surface: On-Cell mAb Screening (OCMS&trade ). Six IgA1 mAbs were cloned by this method three potently neutralized type 3 Sabin and wt PV strains. The hybridoma mAbs were heterogeneous, expressed in monomeric, dimeric, and aberrant forms. We also used recombinant methods to convert two high-potency anti-PV IgG mAbs into dimeric IgA1 and IgA2 mAbs. Isotype switching did not substantially change their neutralization activities. To purify the recombinant mAbs, Protein L binding was used, and one of the mAbs required a single amino acid substitution in its &kappa LC in order to enable protein L binding. Lastly, we used OCMS to assess IgA expression on the surface of hybridomas and transiently transfected, adherent cells. These studies have generated potent anti-PV IgA mAbs, for use in animal models, as well as additional tools for the discovery and production of human IgA mAbs. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |